Reliance Chemotex Industries Ltd

As of June 30, 2026, Reliance Chemotex Industries Ltd carries a market capitalization of 1.01B, placing it among publicly traded companies globally. Its enterprise value stands at 1.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Reliance Chemotex Industries Ltd has 7.54M shares outstanding.

As of June 30, 2026, Reliance Chemotex Industries Ltd trades at a trailing price-to-earnings ratio of 18.10.

As of June 30, 2026, Reliance Chemotex Industries Ltd trades at an EV/EBITDA multiple of 2.47 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.27 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 3.87 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.01B versus a market cap of 1.01B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 1.62M in revenue per employee across its workforce of 2,278.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Reliance Chemotex Industries Ltd recorded an income tax benefit of -3.79M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 51.85M, leaving 55.65M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Reliance Chemotex Industries Ltd's stock has declined approximately 31.13% over the past 52 weeks. The 50-day moving average sits at 114.93, while the 200-day moving average is 122.38.

Over the twelve months ended June 30, 2026, Reliance Chemotex Industries Ltd generated 3.68B in revenue and converted that into 55.65M in net income, yielding earnings per share of 7.37. EBITDA reached 407.54M, while operating income came in at 260.21M.

Over the twelve months ended June 30, 2026, Reliance Chemotex Industries Ltd posted a gross margin of 45.86, reflecting its pricing power and cost economics. The operating margin of 7.06 and net profit margin of 1.51 provide insight into operational efficiency.

Reliance Chemotex Industries Ltd's most recent stock split took place on June 19, 2019.